[1] Said SI,M utt V.Polupeptide with broad biological activity:Isolation from the small intestinal[J].Science,1970,69:1217-1218.
[2] HarmarAJ,Arimura A.International union of pharmacology Ⅹ Ⅷ.nomenclature of receptor for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide[J].Pharmacol Rev,1998,50(2):265-270.
[3] Fahrnkrug J.Glycine-extended processing intermediate of proVIP:A new bioactive form of VIP in the rat[J].Biomed Res,1992,13:19-23.
[4] Bolin DR,Cottrell J.Strycture-activity studies on the vasoactive intestinal peptide pharmacophore[J].Int J Pritein Res,1995,46:279-289.
[5] Wulff B,Moller-Knusen S.The C-terminal part of VIP is importan for receptor binding and activation,as evidenced by chimeric constructs of VIP/secretin[J].FEBS Lett,1997,413(3):405-408.
[6] Usdin TB,Bonner TI.Two receptors for vasoactive intestinal polypeptide with similar specificity and complementary distributions[J].Endocrinology,1994,35(6):2662-2680.
[7] Gaudin P,Couvineau A.Role of cysteine residues in the N-terminal extracellular domain of the humun VIP1 receptor for ligand:A site-directed mutagenesis study[J].Ann NY Acad Sci,1996,805:585-589.
[8] Nicol P,Du K.Site-directed mutagenesis of human VIP1 versus VIP2 receptors[J].Ann N Y Acad Sci,1998,865:378-381.
[9] Nicol P,Du K.Site-directed mutagenesis of humann vasoactive intestinal peptide receptor subtypes VIP1 and VIP2:evidence for difference in the structure-function relationship[J].J Phannacol Exp Ther,1998,284(2):744-750.
[10] Sreedharan SP,Patel DR.Cloning and functional expression of a human neuroendocrine vasoactive intestinal peptide receptor[J].Biochem Biophys Res Commun,1993,193(2):546-553.
[11] Lutz EM,Shen S.Structure of the human VIPR2 sene for vasoactive intestinal peptide receptor type?[J].FEBS Lett,1999,458:197-203.
[12] Gaudin P,Maoret JJ.Constitutive activation of the human vasoactive intestinal peptide 1 receptor,a member of the new class Ⅱ family of G protein-coupled receptors[J].J Biol Chem,1998,273 (9):4990-4996.
[13] Reubi JC.In vitro identification of vasoactive intestinal peptide receptors in human tumors:implications for tumor imaging[J].J Nucl Med,1995,36(10):1846-1895.
[14] Reubi JC,Lamberts ST.Receptor imaging of human diseases using radiolabeled peptides[J].J Recept Signal Transduct Res,1995,15(1-4):379-392.
[15] ReubiJC,Waser B.Receptor autoradiogrphic evaluation of cholecystokinin,neurotensin,somatostatin and vasoactive intestinal peptide receptors in gastro-intestinal adenocarcinoma samples:Where are they really located?[J].Int J Cancer,1999,81(3):376-386.
[16] Virgolini I.Vasoactive intestinal peptide receptor scintigraphy[J].J Nucl Med,1995,36(10):1732-1739.
[17] Virgolini I,Raderer M.Vasoactive intestinal peptide receptor imaging for the localization of intestinal adenocarcinomas and endocrine tumor[J].N Engl J Med,1994,331(17):1116-1121.
[18] Virgolini I,Raderer M.Iodine-123-vasoactive intestinal peptide receptor scanning up-to-date of imaging results in patients with adeocarcinomas and endocrine tumor of the gastrointestinal tract[J].Nucl Med Biol,1996,23(6):685-692.
[19] Pallela VR,Thakur ML.99Tcm-labeled vasoactive intestinal peptide receptor agonist:functional studies[J].J Nucl Med,1999,40(2):352-360.